Legend Biotech's three largest insider shareholders as of September 29, 2026 are Ingrid Zhang (Chief Executive Officer, 1.13Mn shares), Ying Huang (Chief Executive Officer, 238.49K shares), Darren Xiaohui Ji (Director, 92.10K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Ingrid Zhang | Chief Executive Officer | 1,131,860 | 0 | 1,131,860 | 61.7% | 16 Sep, 2026 |
| 2 | Ying Huang | Chief Executive Officer | 238,490 | 0 | 238,490 | 13.0% | 02 Jul, 2026 |
| 3 | Darren Xiaohui Ji | Director | 92,103 | 0 | 92,103 | 5.0% | 28 Sep, 2026 |
| 4 | Corazon (Corsee) D. Sanders | Director | 80,101 | 0 | 80,101 | 4.4% | 28 Sep, 2026 |
| 5 | Patrick John Casey | Director | 69,590 | 0 | 69,590 | 3.8% | 28 Sep, 2026 |
| 6 | Li Mao | Director | 65,316 | 0 | 65,316 | 3.6% | 28 Sep, 2026 |
| 7 | Peter Salovey | Director | 55,096 | 0 | 55,096 | 3.0% | 28 Sep, 2026 |
| 8 | Tomas J. Heyman | Director | 53,720 | 0 | 53,720 | 2.9% | 28 Sep, 2026 |
| 9 | Alan Bash | Interim Ceo | 35,142 | 0 | 35,142 | 1.9% | 18 Aug, 2026 |
| 10 | Carlos E Santos | Chief Financial Officer | 14,246 | 0 | 14,246 | 0.8% | 23 Sep, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 24 Sep, 2026 | Patrick John Casey | Director | Acquired A | 20,986 | $0.00 | $0 | 69,590 | Direct |
| 24 Sep, 2026 | Li Mao | Director | Acquired A | 20,986 | $0.00 | $0 | 65,316 | Direct |
| 24 Sep, 2026 | Peter Salovey | Director | Acquired A | 28,330 | $0.00 | $0 | 55,096 | Direct |
| 24 Sep, 2026 | Corazon (Corsee) D. Sanders | Director | Acquired A | 20,986 | $0.00 | $0 | 80,101 | Direct |
| 24 Sep, 2026 | Darren Xiaohui Ji | Director | Acquired A | 28,330 | $0.00 | $0 | 92,103 | Direct |
| 24 Sep, 2026 | Tomas J. Heyman | Director | Acquired A | 20,986 | $0.00 | $0 | 53,720 | Direct |
| 21 Sep, 2026 | Carlos E Santos | Chief Financial Officer | Acquired A | 19,676 | $0.00 | $0 | 19,676 | Direct |
| 21 Sep, 2026 | Carlos E Santos | Chief Financial Officer | Disposed S | 5,430 | $9.14 | $49.63K | 14,246 | Direct |
| 14 Aug, 2026 | Alan Bash | Interim Ceo | Acquired A | 4,908 | $0.00 | $0 | 35,142 | Direct |
| 30 Jun, 2026 | Patrick John Casey | Director | Disposed S | 6,000 | $14.80 | $88.80K | 48,604 | Direct |
| 30 Jun, 2026 | Ying Huang | Chief Executive Officer | Disposed G | 3,382 | $0.00 | $0 | 238,490 | Direct |
| 25 Jun, 2026 | Ying Huang | Chief Executive Officer | Disposed S | 5,566 | $14.78 | $82.27K | 241,872 | Direct |
| 25 Mar, 2026 | Ying Huang | Chief Executive Officer | Disposed S | 9,936 | $8.77 | $87.14K | 247,438 | Direct |